Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Covington
Fish and Richardson
UBS
Harvard Business School
Moodys
US Army
Chubb
Dow

Generated: October 20, 2017

DrugPatentWatch Database Preview

NALLPEN Drug Profile

« Back to Dashboard

Which patents cover Nallpen, and what generic Nallpen alternatives are available?

Nallpen is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in NALLPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.

Summary for Tradename: NALLPEN

US Patents:0
Applicants:2
NDAs:3
Bulk Api Vendors: see list9
Patent Applications: see list4,090
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NALLPEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
NALLPEN
nafcillin sodium
INJECTABLE;INJECTION062755-001Dec 19, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
NALLPEN IN PLASTIC CONTAINER
nafcillin sodium
INJECTABLE;INJECTION050655-002Oct 31, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Glaxosmithkline
NALLPEN
nafcillin sodium
INJECTABLE;INJECTION061999-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
NALLPEN IN PLASTIC CONTAINER
nafcillin sodium
INJECTABLE;INJECTION050655-001Oct 31, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Glaxosmithkline
NALLPEN
nafcillin sodium
INJECTABLE;INJECTION062755-002Dec 19, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
NALLPEN
nafcillin sodium
INJECTABLE;INJECTION061999-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
NALLPEN
nafcillin sodium
INJECTABLE;INJECTION061999-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
NALLPEN
nafcillin sodium
INJECTABLE;INJECTION061999-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Colorcon
Novartis
Federal Trade Commission
Citi
McKesson
Express Scripts
Baxter
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot